Medical Device Investment

The planned Phase 1 production model is centered in and supported by controlled process ownership and confidential external specialization. The designed run-rate, facility footprint, staffing, and later expansion remain subject to validation and milestone evidence.

Quality, Regulatory, and Evidence Program

TheraMod’s expansion strategy treats registration, quality systems, and evidence as separate but connected workstreams. Registration is market-access status; it does not establish outcomes. Future evidence use remains subject to complete analysis, final reporting, and regulatory/legal review.

Distributor-Led Commercialization

Qualified medical-device distributors and professional buyers are the intended scale channel. Opportunities are assessed through territory, regulatory, training, service, commercial, payment, and claims controls before they are included in planning reliance.

Governance and Related-Party Controls

Founder-affiliated environments may support demonstration, training, workflow learning, service feedback, and potential documented purchases. They are not automatic revenue, independent clinical evidence, or substitutes for third-party distributor demand. Any transaction requires written terms, arm’s-length pricing, applicable approval, and separate accounting.

Controlled Investor Access

Suitable parties may request an introductory management discussion. After investor-fit confirmation and appropriate confidentiality arrangements, access may be provided in stages to the executive brief, financial workbook, evidence index, leadership and governance dossier, buyer-economics analysis, and supporting diligence records.

Important Investment Notice

This page is not an offer to sell securities, a prospectus, a guarantee of financial or clinical outcomes, or a substitute for legal, tax, regulatory, accounting, technical, and financial due diligence. Forecasts and transaction structures remain planning assumptions subject to verification, negotiation, solvency, approvals, and definitive documentation.

Regulatory and Quality Foundation

TheraMod (M) Sdn. Bhd. was incorporated on 12 October 2006. We hold a manufacturer establishment licence and an ISO 13485 quality management system certified in both and Germany.

Registration and certification establish the stated status and quality-system scope. They do not establish clinical outcomes, comparative superiority, foreign-market authorization, or MDA endorsement.

Three Registered Devices

TheraMod holds three active Class A medical device registrations. Each registration names the device, its class, and a defined validity period.

RxDecom® is a controlled spinal distraction device for trained professional settings. Spinercise® is a professional functional-exercise and rehabilitation platform. FD-3000™ is a powered flexion-distraction table.

How TheraMod Reaches Its Market

Equipment sales through qualified distributors and direct professional buyers form the commercial model. We apply a defined sequence.

1. Prioritize commercial reactivation for registered devices once production and release controls are ready.
2. Qualify distributors by territory capability, regulatory knowledge, service capacity, training commitment, claims discipline, and financial terms.
3. Apply cleared funds before shipment as the standard payment policy. Secured exceptions require documentation and board approval.
4. Develop ASEAN, India, and selected MENA markets before committing to physical international hubs.
5. Advance European Union and United States pathways only through product-specific classification, testing, technical files, and adviser-confirmed plans.

Who Buys Professional Rehabilitation Equipment

The buyer universe is professional, not consumer. It includes physiotherapy and rehabilitation centers, chiropractic and non-surgical spine centers, hospitals and specialty clinics, medical device distributors, and sports and performance rehabilitation providers.

Clinical Need

Spine and joint conditions are among the most common causes of disability worldwide, and published health data projects that burden to grow. That is the clinical need TheraMod equipment is built for. It is not a measure of demand for any device, and no market size is claimed on this page.

What This Page Does Not Represent

How to Request the Confidential Materials

Detailed financial models, use-of-funds schedules, buyer economics, supplier information, technical records, and proposed transaction terms are released in stages to qualified parties.

1. Management discussion and investor-fit confirmation.
2. Confidentiality agreement.
3. Staged data-room access.
4. Independent technical, financial, regulatory, tax, and legal diligence.
5. Definitive transaction terms.

No figures, valuations, or transaction terms are published here. Those are shared directly, and only with parties who have made contact and completed a confidentiality agreement.

Interested parties are welcome to get in touch. Qualified investors, strategic partners, healthcare groups, manufacturers, and distributors can write to [email protected] or reach TheraMod through the TheraMod contact page. Management responds directly and will arrange an introductory discussion.

Investor Questions

Is TheraMod making a public offer of securities?

No. This page is a corporate introduction only. No securities are offered here, and nothing on this page is a prospectus, an offer, or an invitation to invest. Detailed materials are released to qualified parties under a confidentiality agreement.

Which TheraMod devices are registered?

Three devices hold active Class A registrations with the Medical Device Authority. RxDecom is registered under GA10689826-235584 to 1 July 2031. Spinercise is registered under GA5390526-240502 to 19 August 2031. FD-3000 is registered under GA6416424-169842 to 27 April 2029.

Does TheraMod manufacture under a certified quality system?

Yes. TheraMod operates under an ISO 13485 quality management system certified under Q2MYS 080272 0004 and in Germany under Q5 080272 0003. We also holds manufacturer establishment licence MDA-5532-K124.

What does TheraMod sell, and to whom?

TheraMod sells professional rehabilitation equipment to trained settings. Buyers include physiotherapy and rehabilitation centers, chiropractic and non-surgical spine centers, hospitals and specialty clinics, medical device distributors, and sports rehabilitation providers. The devices are not consumer products.

Does device registration mean the devices are proven to work?

No. Registration is market access evidence for the registered device and its stated validity period. It does not establish clinical outcomes, comparative superiority, authorization in another market, or endorsement by the Medical Device Authority.

How does an investor request the detailed materials?

The process runs in stages. It begins with a management discussion and investor-fit confirmation, followed by a confidentiality agreement, staged data-room access, independent technical, financial, regulatory, tax and legal diligence, and finally definitive transaction terms.

Start by writing to [email protected]. General inquiries go to [email protected].